Medicines
Zoledronic acid and denosumab, fertility, menopause and sexual health
Zoledronic acid and denosumab act on bone, so they do not cause menopause or directly affect sexual function. They are often given because other treatments have lowered oestrogen and thinned bones. Both may harm a developing baby, so pregnancy needs careful planning. This page explains the general advice and practical support.
On this page
- Do zoledronic acid and denosumab affect fertility, menopause or sexual health?
- How bone medicines relate to fertility and sexual health
- Pregnancy and breastfeeding at a glance
- The vocabulary, in plain language
- What is known and what is not
- If you are premenopausal
- Sex and closeness during bone-directed treatment
- Why early menopause makes bone protection important
- Raising fertility and intimacy with your team
- What people assume about bone medicines and fertility
- Common questions about fertility, menopause and sexual health
The short answer
Do zoledronic acid and denosumab affect fertility, menopause or sexual health?
Zoledronic acid and denosumab act on bone rather than on the ovaries, testes or sex hormones, so they are not known to cause menopause, change periods or directly affect sexual function. Their link with these topics is mostly indirect. Many women receive them because other breast cancer treatments, such as aromatase inhibitors, ovarian suppression or chemotherapy, have lowered oestrogen and brought on menopause, which thins the bones. In early breast cancer, zoledronic acid lowers the chance of cancer returning in bone only in women with low oestrogen, either after natural menopause or with ovarian suppression. The most important issue is pregnancy. Both medicines may harm a developing baby's bones and should not be used in pregnancy. Zoledronic acid binds to bone and is released slowly for years, so pregnancy soon after treatment raises questions that need discussion. For denosumab, the prescribing information advises effective contraception during treatment and for at least five months after the last dose. Breastfeeding is not advised during treatment. Research on fertility in people is limited. Animal studies of zoledronic acid suggested possible effects on fertility, but neither medicine is known to cause infertility in humans. Sexual wellbeing can still be affected by bone pain, tiredness, the flu-like reaction after a drip, and the hormone treatments given alongside. Talking openly with your team helps you find practical support.
They do not cause menopause
Menopause symptoms usually come from other breast cancer treatments.
Avoid pregnancy
Both medicines may harm a developing baby, so contraception matters.
Plan ahead for future pregnancy
Discuss timing with your team, as these medicines have lasting effects.
This page gives general information only. Discuss your own situation with your oncologist.Areas affected
How bone medicines relate to fertility and sexual health
Most effects are indirect, but pregnancy needs careful planning.
Menopause
Not caused by these medicines, but often the reason they are given, because low oestrogen thins bone.
Pregnancy
Both may affect a baby's developing bones and are not used in pregnancy.
Tell your team straight away if you might be pregnant.Fertility
Not known to cause infertility in people, although research is limited.
Sexual wellbeing
Affected indirectly by pain, tiredness and hormone treatments.
Common contributors
- Bone pain and stiffness
- Flu-like days after a drip
- Vaginal dryness from hormone treatment
Precautions
Pregnancy and breastfeeding at a glance
Words you will hear
The vocabulary, in plain language
- Ovarian suppression
- Treatment that switches off the ovaries so they stop making oestrogen.
- Treatment-induced menopause
- Menopause brought on by cancer treatment rather than by age.
- Bone mineral density
- A measure of bone strength, which falls when oestrogen is low.
- Placenta
- The organ that links a mother and baby during pregnancy.
- Non-hormonal contraception
- Methods such as condoms or a copper coil that do not use hormones.
- Vaginal moisturiser
- A non-hormonal product used regularly to relieve dryness.
Being straight with you
What is known and what is not
Research on fertility and pregnancy with these medicines in people is limited, so advice is cautious.
Human data are scarce
Most information comes from animal studies and small numbers of reported pregnancies.
Zoledronic acid lasts a long time
Because it stays in bone for years, no one can say exactly when pregnancy becomes risk-free.
Other treatments matter more for fertility
Chemotherapy and hormone treatment usually have much greater effects on fertility.
What this page cannot tell you
It cannot advise on your own pregnancy plans. Your oncologist and a fertility specialist can.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Younger women
If you are premenopausal
Younger women may meet these medicines in several situations.
With ovarian suppression
Women whose ovaries are switched off may receive zoledronic acid to protect bones and, in early breast cancer, to lower the chance of bone recurrence.
With bone metastases
Women with cancer in the bones receive them to protect the skeleton, regardless of menopause.
When ovaries are working
The anti-recurrence benefit of zoledronic acid has not been shown, so it is not used for that purpose.
Thinking about children
Raise any hopes for future pregnancy early, so treatment can be planned with that in mind.
Intimacy
Sex and closeness during bone-directed treatment
These medicines do not make sex unsafe, but related problems can make it harder.
Plan around drips
The flu-like reaction after a first zoledronic acid drip may leave you tired for a few days.
Protect painful areas
With bone metastases, supportive pillows and gentle positions can make intimacy more comfortable.
Ease dryness
Vaginal moisturisers and lubricants help with dryness caused by hormone treatment.
Talk openly
Share what feels comfortable with your partner, and ask your team for specialist support if needed.
Bones and menopause
Why early menopause makes bone protection important
Oestrogen helps keep bones strong. When it drops suddenly, bone loss can be rapid.
Faster bone loss
Treatment-induced menopause and aromatase inhibitors can thin bones more quickly than natural ageing.
Checking bone health
A DEXA scan measures bone density and helps decide whether a bone medicine is needed.
Helping yourself
Weight-bearing activity, calcium, vitamin D and avoiding tobacco support bone strength.
Talking about it
Raising fertility and intimacy with your team
Questions about pregnancy and sex can feel awkward to raise, especially when family members come to appointments. Your team is used to these conversations.
Write questions down
A short list helps you remember what to ask about contraception, pregnancy timing and comfort.
Ask for privacy
You can request a few minutes alone with your doctor or nurse.
Seek specialist help
Fertility specialists, gynaecologists and counsellors can support you and your partner.
Commonly believed
What people assume about bone medicines and fertility
They do not. Other treatments usually cause menopause.
Effects can last, so timing should be discussed with your team.
They do not. Pain, tiredness and dryness are the usual obstacles.
Younger women with treatment-induced menopause can lose bone quickly.
Questions we are asked
Common questions about fertility, menopause and sexual health
Will zoledronic acid stop my periods?
No. Zoledronic acid does not act on the ovaries. If your periods have stopped, it is more likely due to chemotherapy, ovarian suppression or natural menopause. Your team can explain what is causing the change in your situation.
How long after denosumab should I wait before pregnancy?
The prescribing information advises contraception for at least five months after the last dose. However, pregnancy after breast cancer involves many other considerations, including other treatments. Discuss your plans with your oncologist well in advance.
Is pregnancy possible after zoledronic acid?
Some women have had healthy pregnancies after bisphosphonate treatment, but research is limited. Because the medicine stays in bone, your oncologist will talk through possible risks and timing, alongside the effects of your other breast cancer treatments.
What if I become pregnant during treatment?
Tell your team straight away. Bone-directed treatment will usually be paused, and your oncologist and an obstetrician will discuss the situation with you openly and support you in any decision.
Do these medicines affect men's fertility?
They are not known to cause infertility in men, although human research is limited. Men receiving other hormone treatments may notice changes in desire or erections. Ask your team whether any contraception advice applies to you.
Can I breastfeed while having treatment?
Breastfeeding is not advised during treatment with zoledronic acid or denosumab, because effects on a baby are not known. Most women with breast cancer are also on other treatments that make breastfeeding unsuitable.
Why am I on bone protection when I am young?
Treatments such as ovarian suppression and aromatase inhibitors lower oestrogen sharply, which can thin bones at any age. A bone medicine may protect your bones and, in some early breast cancers, lower the chance of recurrence in bone.
Can bone pain affect my sex life?
Yes. Pain and stiffness can make intimacy difficult. Good pain control, supportive positions and choosing times when you feel best can help. A physiotherapist or counsellor can offer practical ideas.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Sources
- European Medicines Agency — Xgeva product information
- MedlinePlus — Zoledronic acid injection
- National Cancer Institute — Fertility issues in girls and women with cancer
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.